These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 12230860

  • 1. It is not unethical, though it is often unwise, to override patents.
    Leventer H.
    Am J Bioeth; 2002; 2(3):50-1. PubMed ID: 12230860
    [No Abstract] [Full Text] [Related]

  • 2. The Cipro patent and bioterrorism.
    Kaye KS, Kaye D.
    Am J Bioeth; 2002; 2(3):41-2. PubMed ID: 12230854
    [No Abstract] [Full Text] [Related]

  • 3. Compulsory licensure: the case of Cipro and beyond.
    Chakrabarty AM.
    Am J Bioeth; 2002; 2(3):40. PubMed ID: 12230853
    [No Abstract] [Full Text] [Related]

  • 4. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB, DeVille KA.
    Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
    [No Abstract] [Full Text] [Related]

  • 5. Not taking, just borrowing: government use of patented drugs.
    Ossorio PN.
    Am J Bioeth; 2002; 2(3):51-2. PubMed ID: 12230861
    [No Abstract] [Full Text] [Related]

  • 6. Patents: the public interest versus the private privilege.
    Parsi KP, Egan EA.
    Am J Bioeth; 2002; 2(3):45-6. PubMed ID: 12230857
    [No Abstract] [Full Text] [Related]

  • 7. Who are the guardians guarding?
    Trachtman H.
    Am J Bioeth; 2002; 2(3):46-8. PubMed ID: 12230858
    [No Abstract] [Full Text] [Related]

  • 8. Life, death, and monopoly rights in a democratic society.
    Smith SJ.
    Am J Bioeth; 2002; 2(3):43-4. PubMed ID: 12230856
    [No Abstract] [Full Text] [Related]

  • 9. Patent immorality?
    Bloche MG, Jungman ER.
    Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
    [No Abstract] [Full Text] [Related]

  • 10. The burgeoning science of genetics and the impact on public policy.
    Hatch OG.
    J Biolaw Bus; 2004; 7(4):3-6. PubMed ID: 15675088
    [Abstract] [Full Text] [Related]

  • 11. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E.
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract] [Full Text] [Related]

  • 12. Beyond government intervention: drug companies and bioethics.
    Dresser R.
    Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855
    [No Abstract] [Full Text] [Related]

  • 13. Pharmaceuticals and medical devices: business practices.
    Health Policy Tracking Service, a service of Thomson Reuters Accelus, Steiner DJ.
    Issue Brief Health Policy Track Serv; 2012 Jan 03; ():1-35. PubMed ID: 22423396
    [No Abstract] [Full Text] [Related]

  • 14. Pharmaceuticals and medical devices: business practices. Issue brief.
    Steiner DJ.
    Issue Brief Health Policy Track Serv; 2012 Dec 31; ():1-36. PubMed ID: 23297448
    [No Abstract] [Full Text] [Related]

  • 15. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM.
    Am J Law Med; 2001 Dec 31; 27(4):469-85. PubMed ID: 11837145
    [No Abstract] [Full Text] [Related]

  • 16. Gene patents--a pharmaceutical perspective.
    Tribble JL.
    Camb Q Healthc Ethics; 1998 Dec 31; 7(4):429-32. PubMed ID: 9752585
    [No Abstract] [Full Text] [Related]

  • 17. Biotech patents-business as usual?
    Lawrence S.
    Nat Biotechnol; 2008 Dec 31; 26(12):1326. PubMed ID: 19060861
    [No Abstract] [Full Text] [Related]

  • 18. A license to print money?
    Nat Biotechnol; 2006 Jun 31; 24(6):593. PubMed ID: 16763570
    [No Abstract] [Full Text] [Related]

  • 19. Patent crunch pending.
    Wadman M.
    Nature; 2007 Oct 11; 449(7163):651. PubMed ID: 17968400
    [No Abstract] [Full Text] [Related]

  • 20. Patents: a threat to innovation?
    Manocaran M.
    Science; 2010 Jan 01; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.